COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes (2021)
- Authors:
- Yokoyama, Ana Paula Hitomi

- Wendel, Silvano

- Bub, Carolina Bonet

- Fachini, Roberta M.
- Dametto, Ana Paula F.
- Blumm, Fernando
- Dutra, Valeria F.

- Candelaria, Gabriela T. P.

- Sakashita, Araci M.
- Machado, Rafael Rahal Guaragna

- Wendel, Rita Fontão
- Hamerschlak, Nelson

- Achkar, Ruth
- Assunção, Murillo Santucci Cesar

- Scuracchio, Patrícia
- Nudelman, Victor
- Pastore, Laerte
- Pinho, João R. R.
- Ben, Mirian Dal
- Kalil Filho, Roberto

- Marra, Alexandre R.
- Amano, Mariane Tami

- Kallás, Esper Georges

- Helito, Alfredo Salim
- Carvalho, Carlos Roberto Ribeiro De

- Araujo, Danielle Bastos

- Durigon, Edison Luiz

- Camargo, Anamaria Aranha

- Rizzo, Luiz V.

- Reis, Luiz F. L.

- Kutner, José Mauro

- Yokoyama, Ana Paula Hitomi
- USP affiliated authors: KALIL FILHO, ROBERTO - FM ; KALLAS, ESPER GEORGES - FM ; CARVALHO, CARLOS ROBERTO RIBEIRO DE - FM ; DURIGON, EDISON LUIZ - ICB ; MACHADO, RAFAEL RAHAL GUARAGNA - ICB
- Unidades: FM; ICB
- DOI: 10.1111/trf.16573
- Subjects: MICROBIOLOGIA; COVID-19; TRANSFUSÃO DE SANGUE; PLASMA; ANTICORPOS; ESTUDOS DE COORTES; PACIENTES; UNIDADES DE TERAPIA INTENSIVA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Transfusion
- ISSN: 1537-2995
- Volume/Número/Paginação/Ano: p. 1-12, 2021
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- PDF de acesso aberto
- Versão do Documento: Versão publicada (Published version)
-
Status: Artigo possui acesso gratuito no site do editor (Bronze Open Access) -
ABNT
YOKOYAMA, Ana Paula Hitomi et al. COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes. Transfusion, p. 1-12, 2021Tradução . . Disponível em: https://doi.org/10.1111/trf.16573. Acesso em: 15 mar. 2026. -
APA
Yokoyama, A. P. H., Wendel, S., Bub, C. B., Fachini, R. M., Dametto, A. P. F., Blumm, F., et al. (2021). COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes. Transfusion, 1-12. doi:10.1111/trf.16573 -
NLM
Yokoyama APH, Wendel S, Bub CB, Fachini RM, Dametto APF, Blumm F, Dutra VF, Candelaria GTP, Sakashita AM, Machado RRG, Wendel RF, Hamerschlak N, Achkar R, Assunção MSC, Scuracchio P, Nudelman V, Pastore L, Pinho JRR, Ben MD, Kalil Filho R, Marra AR, Amano MT, Kallás EG, Helito AS, Carvalho CRRD, Araujo DB, Durigon EL, Camargo AA, Rizzo LV, Reis LFL, Kutner JM. COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes [Internet]. Transfusion. 2021 ; 1-12.[citado 2026 mar. 15 ] Available from: https://doi.org/10.1111/trf.16573 -
Vancouver
Yokoyama APH, Wendel S, Bub CB, Fachini RM, Dametto APF, Blumm F, Dutra VF, Candelaria GTP, Sakashita AM, Machado RRG, Wendel RF, Hamerschlak N, Achkar R, Assunção MSC, Scuracchio P, Nudelman V, Pastore L, Pinho JRR, Ben MD, Kalil Filho R, Marra AR, Amano MT, Kallás EG, Helito AS, Carvalho CRRD, Araujo DB, Durigon EL, Camargo AA, Rizzo LV, Reis LFL, Kutner JM. COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes [Internet]. Transfusion. 2021 ; 1-12.[citado 2026 mar. 15 ] Available from: https://doi.org/10.1111/trf.16573 - Cross-lineage protection between chikv primary infection and mayv secondary exposure in mice
- Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial
- Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program
- A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections
- Anti‐A and SARS‐CoV‐2: an intriguing association
- Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial
- Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: triple-blind clinical trial
- Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be?
- Soroprevalência da infecção pelos vírus Zika (ZIKV) e Dengue (DENV) em parturientes e transferência transplacentária de anticorpos anti-ZIKV e anti- DENV em neonatos na cidade de São Paulo, Brasil
- No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
